Cell therapy trials generate documentation that traditional pharmaceutical trials do not: apheresis records, manufacturing chain-of-custody logs, cell product characterization reports, individualized lot release documents, and complex logistics tracking for products with limited viability windows. None of these fit neatly into the Reference Model's existing artifacts.

"We cannot simply force these documents into zones where they do not belong," Dr. Okonkwo tells her team during their planning meeting. "But we also cannot abandon the Reference Model entirely. Our CRO partners, our eTMF vendor, and ultimately our regulatory inspectors all expect Reference Model alignment. The question is how to customize thoughtfully."

This is the challenge every organization eventually faces. The DIA TMF Reference Model provides a standardized framework, but no framework can anticipate every therapeutic area, every regulatory jurisdiction, and every organizational workflow. Customization is not merely permitted; it is expected. But customization done poorly creates interoperability problems, inspection confusion, and operational inefficiency.

In this lesson, you will learn when customization serves your organization, what elements of the Reference Model should remain unchanged, and how to document your customizations in ways that preserve the benefits of standardization.

Cell therapy trials generate documentation that traditional pharmaceutical trials do not: apheresis records, manufacturing chain-of-custody logs, cell product characterization reports, individualized lot release documents, and complex logistics tracking for products with limited viability windows. None of these fit neatly into the Reference Model's existing artifacts.

"We cannot simply force these documents into zones where they do not belong," Dr. Okonkwo tells her team during their planning meeting. "But we also cannot abandon the Reference Model entirely. Our CRO partners, our eTMF vendor, and ultimately our regulatory inspectors all expect Reference Model alignment. The question is how to customize thoughtfully."

This is the challenge every organization eventually faces. The DIA TMF Reference Model provides a standardized framework, but no framework can anticipate every therapeutic area, every regulatory jurisdiction, and every organizational workflow. Customization is not merely permitted; it is expected. But customization done poorly creates interoperability problems, inspection confusion, and operational inefficiency.

In this lesson, you will learn when customization serves your organization, what elements of the Reference Model should remain unchanged, and how to document your customizations in ways that preserve the benefits of standardization.